RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
15.89
-0.12 (-0.75%)
At close: May 22, 2025, 4:00 PM
15.89
0.00 (0.00%)
After-hours: May 22, 2025, 4:04 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $645.72 million as of May 22, 2025. Its market cap has decreased by -72.37% in one year.
Market Cap
645.72M
Enterprise Value
424.77M
1-Year Change
-72.37%
Ranking
Category
Stock Price
$15.89
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $645.72M, an increase of 52.17%. That is a compound annual growth rate of 11.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2025 | 650.60M | -53.05% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.81B |
| Johnson & Johnson | 368.56B |
| AbbVie | 321.13B |
| Novo Nordisk | 308.07B |
| UnitedHealth Group | 274.85B |
| Abbott Laboratories | 231.49B |
| Novartis AG | 222.59B |
| AstraZeneca | 218.71B |